Results 191 to 200 of about 12,958 (242)

Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies. [PDF]

J Relig Health
Lewis SP, Clark-Soles J, Mayorga O, Sawyer SK, Slavet E, Vidt BJ, Shanti S, Wiggins R, Willis K, Frey J, Grace RM, Cherniak AD.   +11 more
europepmc   +1 more source

Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration. [PDF]

Int J Mol Sci
Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E.   +4 more
europepmc   +1 more source

Age moderates the relationship between psychedelics use and mental health in naturalistic settings

Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Psychedelics and Psychotherapy

Pharmacopsychiatry, 2020
AbstractPsychedelics have shown great promise in modern clinical trials for treating various psychiatric conditions. As a transdiagnostic treatment that exerts its effects through subjective experiences that leave enduring effects, it is akin to psychotherapy.
Sandeep, Nayak, Matthew W, Johnson
openaire   +2 more sources

Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?

International Review of Psychiatry
Personal psychedelic experience is common among psychedelic therapists and often considered to be a necessary aspect of training: Only personal psychedelic experience allows psychedelic therapists to properly guide patients through their own psychedelic ...
Daniel Villiger
exaly   +3 more sources

Psychedelics and connectedness

Psychopharmacology, 2017
Psychedelic drugs are creating ripples in psychiatry as evidence accumulates of their therapeutic potential. An important question remains unresolved however: how are psychedelics effective? We propose that a sense of connectedness is key, provide some preliminary evidence to support this, and suggest a roadmap for testing it further.
R L, Carhart-Harris, D, Erritzoe, E, Haijen, M, Kaelen, R, Watts   +4 more
openaire   +2 more sources

Psychedelics and schizophrenia

Trends in Neurosciences, 2009
Research on psychedelics such as lysergic acid diethylamide (LSD) and dissociative drugs such as phencyclidine (PCP) and the symptoms, neurochemical abnormalities and treatment of schizophrenia have converged. The effects of hallucinogenic drugs resemble some of the core symptoms of schizophrenia.
Javier, González-Maeso, Stuart C, Sealfon   +1 more
openaire   +2 more sources

Psychedelics as Transformative Therapeutics

American Journal of Psychiatry, 2023
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor.
Bryan L, Roth, Ryan H, Gumpper
openaire   +2 more sources